Bioservo signs an agreement for the sales of Carbonhand® with Ergo Diffusion in France

Bioservo Technologies AB, together with Ergo Diffusion, has signed a distribution agreement for the sales of Carbonhand® in France. The agreement is part of the company's investment in strengthening the sales network within the Life Science area in Europe.

Since 2009, Ergo Diffusion has worked to provide French users with aids for increased independence. The grip-enhancing glove Carbonhand from Bioservo becomes a natural complement to their existing product portfolio, which today includes armrests, robotic arms and aids for eating and drinking.

The company has a well-established network of prescribers, rehabilitation clinics, hospitals and nursing homes, as well as good knowledge of the reimburcement system in France, which is a prerequisite for successfully selling Carbonhand on the French market. These clinics are reached through a network of around 20 local retailers around the country, with a turnover from 1 to 19 M€.

"France has a system for the prescription of assistive devices at regional and local level for people in need of assistive devices, for those returning to work after an accident or illness or those in need of rehabilitation. Through Ergo Diffusion's wide network of retailers as well as a well-established market position among rehabilitation clinics as well as other healthcare facilities, we see great opportunities for a successful introduction of Carbonhand in one of Europe's largest markets." says Petter Bäckgren, CEO at Bioservo

For more information, please contact
Petter Bäckgren, VD, Bioservo Technologies AB
Telefon: 08 21 17 10
[email protected]

Mikael Wester, Marknadsdirektör, Bioservo Technologies AB
Telefon: 08 21 17 10
[email protected]


About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB is the company’s Certified Adviser on Nasdaq First North
For more information, please visit www.bioservo.com